Response to "Interaction of Dasabuvir With Clopidogrel: Did Predictions by Physiologically Based Pharmacokinetics Modeling Pass the Test?"

Itkonen, Matti K; Tornio, Aleksi; Lapatto-Reiniluoto, Outi; Neuvonen, Mikko; Neuvonen, Pertti J; Niemi, Mikko; Backman, Janne T

Itkonen, Matti K; Tornio, Aleksi; Lapatto-Reiniluoto, Outi; Neuvonen, Mikko; Neuvonen, Pertti J; Niemi, Mikko; Backman, Janne T.

Afiliação

Itkonen MK; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Tornio A; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Lapatto-Reiniluoto O; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Neuvonen M; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Neuvonen PJ; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Niemi M; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Backman JT; Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Clin Pharmacol Ther ; 105(2): 322, 2019 02.

Article em En | MEDLINE | ID: mdl-30226021

Assuntos

Clopidogrel; Ritonavir; 2-Naftilamina; Sulfonamidas; Uracila/análogos & derivados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ritonavir / Clopidogrel Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google